# Maze Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2026

- Company: [Maze Therapeutics, Inc.](/companies/maze.md) (CIK 1842295)
- Form: DEF 14A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 16:30 ET
- Period: 2026-06-08
- Accession: 0001140361-26-017463
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-017463. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.